Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
The Journal of Rheumatology|July 1, 2022
Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With GoutGeorge B Coleman, Nicola Dalbeth, Chris Frampton, et al.
Arthritis Care & Research|January 3, 2023
Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography StudyLeanne Chen, Gregory D Gamble, Anne Horne, et al.
The Journal of Rheumatology|August 1, 2024
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating AllopurinolAdwoa Dansoa Tabi-Amponsah, Lisa K Stamp, Anne Horne, et al.
Annals of the Rheumatic Diseases|August 13, 2014
Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)Opetaia Aati, William J Taylor, Richard J Siegert, et al.
Pageof 4